Deutsch English Français

Contact

EP3408286

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP3408286

EP3408286 - G PROTEINS [Right-click to bookmark this link]
Status	Grant of patent is intended Status updated on 04.06.2024 Database last updated on 13.07.2024
Former	Examination is in progress Status updated on 12.11.2019
Former	Request for examination was made Status updated on 02.11.2018
Former	The international publication has been made Status updated on 04.08.2017
Former	unknown Status updated on 08.03.2017
Most recent event Tooltip	04.06.2024	New entry: Communication of intention to grant a patent
Applicant(s)	For all designated states Nxera Pharma UK Limited Granta Park Great Abington Cambridge, Cambridgeshire CB21 6DG / GB
	[2024/25]
Former [2019/12]	For all designated states Heptares Therapeutics Limited Granta Park Great Abington Cambridge CB21 6DG / GB
Former [2018/49]	For all designated states Heptares Therapeutics Limited BioPark Broadwater Road Welwyn Garden City, Hertfordshire AL7 3AX / GB
Inventor(s)	01 / CARPENTER, Byron Medical Research Council Polaris House North Star Avenue Swindon SN2 1FL / GB
	02 / LESLIE, Andrew Medical Research Council Polaris House North Star Avenue Swindon SN2 1FL / GB
	03 / NEHMÉ, Rony Medical Research Council Polaris House North Star Avenue Swindon SN2 1FL / GB
	04 / TATE, Christopher Gordon Medical Research Council Polaris House North Star Avenue Swindon SN2 1FL / GB
	05 / WARNE, Antony Medical Research Council Polaris House North Star Avenue Swindon SN2 1FL / GB
	[2018/49]
Representative(s)	Gill Jennings & Every LLP The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
	[N/P]
Former [2018/49]	Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB
Application number, filing date	17707651.0	27.01.2017
	[2018/49]
	WO2017GB50221
Priority number, date	GB20160001690	29.01.2016 Original published format: GB 201601690
	[2018/49]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2017129998
	Date:	03.08.2017
	Language:	EN
	[2017/31]
	Type:	A1 Application with search report
	No.:	EP3408286
	Date:	05.12.2018
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 03.08.2017 takes the place of the publication of the European patent application.
	[2018/49]
Search report(s)	International search report - published on:	EP	03.08.2017
Classification	IPC:	C07K14/47	[2018/49]
	CPC:	C12N9/14 (EP,US); C07K14/4722 (EP,GB,US); A61P35/00 (EP); C07K14/705 (GB); C07K14/70571 (GB); C07K14/723 (GB); (+) C12Y306/05001 (EP,US); G01N33/566 (GB); G01N2500/02 (GB); G01N2500/04 (GB) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/49]
Title	German:	G-PROTEINE	[2018/49]
	English:	G PROTEINS	[2018/49]
	French:	PROTÉINES G	[2018/49]
Entry into regional phase	24.07.2018	National basic fee paid
	24.07.2018	Designation fee(s) paid
	24.07.2018	Examination fee paid
Examination procedure	24.07.2018	Examination requested [2018/49]
	24.07.2018	Date on which the examining division has become responsible
	05.03.2019	Amendment by applicant (claims and/or description)
	15.11.2019	Despatch of a communication from the examining division (Time limit: M06)
	02.06.2020	Reply to a communication from the examining division
	28.05.2021	Despatch of a communication from the examining division (Time limit: M06)
	06.12.2021	Reply to a communication from the examining division
	05.06.2024	Communication of intention to grant the patent
Fees paid	Renewal fee
	22.01.2019	Renewal fee patent year 03
	23.01.2020	Renewal fee patent year 04
	25.01.2021	Renewal fee patent year 05
	25.01.2022	Renewal fee patent year 06
	25.01.2023	Renewal fee patent year 07
	14.12.2023	Renewal fee patent year 08
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[X]WO9816557 (GEN HOSPITAL CORP [US]) [X] 1-3,10,12,14-19,21-26,47-49,55,58,59 * the whole document *;
		[X]WO2004092199 (CUE BIOTECH INC [US], et al) [X] 1-3,10,12,14-19,21-26,47-49,55,58,59 * the whole document *;
		[X] - R. RUSINOVA ET AL, "Specificity of Gbeta Signaling to Kir3 Channels Depends on the Helical Domain of Pertussis Toxin-sensitive G Subunits", JOURNAL OF BIOLOGICAL CHEMISTRY, US, (20071223), vol. 282, no. 47, doi:10.1074/jbc.M704928200, ISSN 0021-9258, pages 34019 - 34030, XP055360889 [X] 1-3,10,12,14-19,21-26,47-49,55,58,59 * the whole document * DOI: http://dx.doi.org/10.1074/jbc.M704928200
		[A] - TILMAN FLOCK ET AL, "Universal allosteric mechanism for G[alpha] activation by GPCRs", NATURE, United Kingdom, (20150813), vol. 524, no. 7564, doi:10.1038/nature14663, ISSN 0028-0836, pages 173 - 179, XP055371482 [A] 1-117 * the whole document * DOI: http://dx.doi.org/10.1038/nature14663
		[XP] - CARPENTER BYRON ET AL, "Engineering a minimal G protein to facilitate crystallisation of G protein-coupled receptors in their active conformation.", PROTEIN ENGINEERING, DESIGN & SELECTION, (20160926), vol. 29, no. 12, doi:10.1093/protein/gzw049, ISSN 1741-0134, pages 583 - 594, XP002770055 [XP] 1-117 * the whole document * DOI: http://dx.doi.org/10.1093/protein/gzw049
		[XP] - CARPENTER BYRON ET AL, "Structure of the adenosine A(2A) receptor bound to an engineered G protein.", NATURE, (20160804), vol. 536, no. 7614, doi:10.1038/nature18966, ISSN 1476-4687, pages 104 - 107+12pp, XP002770056 [XP] 1-117 * the whole document * DOI: http://dx.doi.org/10.1038/nature18966
	by applicant	EP0184187
		EP0239400
		GB2188638
		WO9532425
		WO2008068534
		WO2008114020
		WO2009071914
		WO2009081136
		WO2010149964
		WO2012007593
		WO2014122183
		WO2015121092
		- OVERINGTON ET AL., NATURE REV. DRUG DISCOVERY, (2006), vol. 5, pages 993 - 996
		- FOORD ET AL., PHARMACOL REV, (2005), vol. 57, pages 279 - 288
		- URANO ET AL., OPEN BIOL., (201303), vol. 3, no. 3, page 120186
		- FLOCK ET AL., NATURE, (2015), vol. 524, page 173
		- ANANTHARANMAN ET AL., GENE, (2011), vol. 475, pages 63 - 78
		- ALEXANDER ET AL., "The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors", BR J PHARMACOL., (2015), vol. 172, pages 5744 - 5869
		- PLANT ET AL., ANALYT BIOCHEM, (1995), vol. 226, no. 2, pages 342 - 348
		- NEVES ET AL., SCIENCE, (2002), vol. 296, pages 1636 - 1639
		- CABRERA-VERA ET AL., ENDOCRINE REVIEWS, (2013), vol. 24, pages 765 - 781
		- G MILLIGAN,, Signal Transduction: A Practical Approach, OXFORD UNIVERSITY PRESS
		- BORLE, ENVIRON HEALTH PERSPECT, (1990), vol. 84, pages 45 - 56
		- GONZALEZ JE; MAHER MP., "Cellular fluorescent indicators and voltage/ion probe reader (VIPR) tools for ion channel and receptor drug discovery.", RECEPTORS CHANNELS., (2002), vol. 8, no. 5-6, doi:doi:10.1080/10606820214644, pages 283 - 95, XP009037013 DOI: http://dx.doi.org/10.1080/10606820214644
		- DUPRIEZ VJ; MAES K; LE POUL E; BURGEON E; DETHEUX M., "Aequorin-based functional assays for G-protein-coupled receptors, ion channels, and tyrosine kinase receptors", RECEPTORS CHANNELS., (2002), vol. 8, no. 5-6, doi:doi:10.1080/10606820214646, pages 319 - 30, XP009055298 DOI: http://dx.doi.org/10.1080/10606820214646
		- WEBER M; FERRER M; ZHENG W; INGLESE J; STRULOVICI B; KUNAPULI P.A, "1536-well cAMP assay for Gs- and Gi-coupled receptors using enzyme fragmentation complementation.", ASSAY DRUG DEV TECHNOL, (200402), vol. ;2, no. 1, pages 39 - 49
		- LEROY D; MISSOTTEN M; WALTZINGER C; MARTIN T; SCHEER A., "G protein-coupled receptor-mediated ERK1/2 phosphorylation: towards a generic sensor of GPCR activation", J RECEPT SIGNAL TRANSDUCT RES., (2007), vol. 27, no. 1, pages 83 - 97
		- LIU B; WU D., "Analysis of the coupling of G12/13 to G protein-coupled receptors using a luciferase reporter assay.", METHODS MOL BIOL., (2004), vol. 237, pages 145 - 9
		- KENT TC; THOMPSON KS; NAYLOR LH., "Development of a generic dual-reporter gene assay for screening G-protein-coupled receptors", J BIOMOL SCREEN., (200508), vol. 10, no. 5, pages 437 - 46
		- HUDSON CC; OAKLEY RH; SJAASTAD MD; LOOMIS CR., "High-content screening of known G protein-coupled receptors by arrestin translocation", METHODS ENZYMOL, (2006), vol. 414, pages 63 - 78
		- JAMESON EE; ROOF RA; WHORTON MR; MOSBERG HI; SUNAHARA RK; NEUBIG RR; KENNEDY RT., "Real-time detection of basal and stimulated G protein GTPase activity using fluorescent GTP analogues", J BIOL CHEM., (20050304), vol. 280, no. 9, pages 7712 - 9
		- RODGERS G; HUBERT C; MCKINZIE J; SUTER T; STATNICK M; EMMERSON P; STANCATO L., "Development of displacement binding and GTPgammaS scintillation proximity assays for the identification of antagonists of the micro-opioid receptor.", ASSAY DRUG DEV TECHNOL., (200310), vol. 1, no. 5, pages 627 - 36
		- LEFF, TIPS, (1995), vol. 16, page 89
		- KENAKIN T., ANN N Y ACAD SCI, (1997), vol. 812, pages 116 - 125
		- THOMPSON ET AL., NUCLEIC ACIDS RES., (1994), vol. 22, no. 22, pages 4673 - 80
		- SAMBROOK, J. & RUSSELL, D.W., Molecular cloning, a laboratory manual, third edition,, COLD SPRING HARBOR LABORATORY PRESS
		- HUBBELL, W.L. ET AL., ADV. PROTEIN. CHEM, (2003), vol. 63, pages 243 - 290
		- BANERES, J.L., J. BIOL. CHEM., (2005), vol. 280, pages 20253 - 20260
		- KOBILKA, B.K.; DEUPI, X., TRENDS. PHARMACOL. SCI, (2007), vol. 28, pages 397 - 406
		- FOORD ET AL., PHARMACOL. REV., (2005), vol. 57, pages 279 - 288
		- FREDRIKSSON ET AL., MOL PHARMACOL, (2003), vol. 63, pages 1256 - 1272
		- FOORD ET AL., PHARMACOL. REV, (2005), vol. 57, pages 279 - 288
		- BOCKAERT ET AL., CURR OPINION DRUG DISCOV AND DEV, (2004), vol. 7, pages 649 - 657
		- KERR ET AL., JACS, (1993), vol. 115, pages 2529 - 2531
		- BRENNER; LERNER, PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, pages 5381 - 5383
		- OHLMEYER ET AL., PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 109222 - 10926
		- MACLEAN ET AL., PROC. NATL. ACAD. SCI. USA, (1997), vol. 94, pages 2805 - 2810
		- SEBESTYEN ET AL., PEPT. PROC. EUR. PEPT. SYMP. 22ND, (1992), pages 63 - 64
		- MORAN ET AL., JACS, (1995), vol. 117, pages 10787 - 10788
		- NEUBIG ET AL., PHARMACOL. REV., (2003), vol. 55, pages 597 - 606
		- NEWMAN-TANCREDI, NEUROPHAMACOLOGY, (1997), vol. 36, pages 451 - 459
		- ROBERTS; STRANGE, BR. J. PHARMACOL, (2005), vol. 145, pages 34 - 42
		- SAVINAINEN ET AL., BR. J. PHARMACOL, (2005), vol. 145, pages 636 - 645
		- MILLIGAN; WHITE, TRENDS PHARMACOL. SCI., (2001), vol. 22, pages 513 - 518
		- BOCKAERT ET AL., CURR. OPINION DRUG DISCOV. DEV., (2004), vol. 7, pages 649 - 657
		- KYLE; DOLITTLE, J. MOL. BIOL., (1982), vol. 157, pages 105 - 132
		- SKERRA, J BIOTECHNOL, (2001), vol. 74, no. 4, pages 257 - 75
		- EGLEN R.M., "Functional G protein-coupled receptor assays for primary and secondary screening.", COMB CHEM HIGH THROUGHPUT SCREEN., (200506), vol. 8, no. 4, pages 311 - 8, XP008058532
		- KOHLER; MILSTEIN, NATURE, (1975), vol. 256, page 495
		- JONES ET AL., ACTA CRYSTALLOGR., (1991), vol. A47, pages 110 - 119
		- CARSON, J. APPL. CRYSTALLOGR., (1991), vol. 24, pages 9589 - 961
		- N. C. COHEN ET AL., "Molecular Modeling Software and Methods for Medicinal Chemistry", J. MED. CHEM, (1990), vol. 33, doi:doi:10.1021/jm00165a001, pages 883 - 894, XP002950820 DOI: http://dx.doi.org/10.1021/jm00165a001
		- M. A. NAVIA; M. A. MURCKO, "The Use of Structural Information in Drug Design", CURRENT OPINIONS IN STRUCTURAL BIOLOGY, (1992), vol. 2, doi:doi:10.1016/0959-440X(92)90147-Y, pages 202 - 210, XP025832107 DOI: http://dx.doi.org/10.1016/0959-440X(92)90147-Y
		- "A Perspective of Modern Methods in Computer-Aided Drug Design", L. M. BALBES ET AL., Reviews in Computational Chemistry, VCH, (1994), vol. 5, pages 337 - 380
	- W. C. GUIDA, "Software For Structure-Based Drug Design", CURR. OPIN. STRUCT. BIOLOGY, (1994), vol. 4, doi:doi:10.1016/S0959-440X(94)90179-1, pages 777 - 781, XP025675913 DOI: http://dx.doi.org/10.1016/S0959-440X(94)90179-1
	- CORNELL, "A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (1995), vol. 117, no. 19, doi:doi:10.1021/ja00124a002, pages 5179 - 97, XP002997435 DOI: http://dx.doi.org/10.1021/ja00124a002
	- LEBON, G. ET AL., "Agonist-bound adenosine A2A receptor structures; reveal common features; of GPCR activation", NATURE, (2011), vol. 474, no. 7352, pages 521 - 5
	- ROSENBAUM, D. M.; LYONS ET AL., "Structure and function of an irreversible agonist-?(2) adrenoceptor complex", NATURE, (2011), vol. 469, no. 7329, pages 236 - 40
	- WARNE, T. ET AL., "The structural basis for agonist and partial agonist action on a P(1)-adrenergic receptor", NATURE, (2011), vol. 469, no. 7329, pages 241 - 4
	- XU, F. ET AL., "Structure of an agonist-bound human A2A adenosine receptor", SCIENCE, (2011), vol. 332, no. 6027, doi:doi:10.1126/science.1202793, pages 322 - 7, XP002680157 DOI: http://dx.doi.org/10.1126/science.1202793
	- HERRMANN, R. ET AL., "Sequence of interactions in receptor-G protein coupling", J BIOL CHEM, (2004), vol. 279, no. 23, pages 24283 - 24290
	- HERRMANN, R. ET AL., "Rhodopsin-transducin coupling: role of the Galpha C-terminus in nucleotide exchange catalysis.", VISION RES, (2006), vol. 46, no. 27, doi:doi:10.1016/j.visres.2006.07.027, pages 4582 - 4593, XP025009951 DOI: http://dx.doi.org/10.1016/j.visres.2006.07.027
	- HAMM, H. E. ET AL., "Site of G protein binding to rhodopsin mapped with synthetic peptides from the alpha subunit", SCIENCE, (1988), vol. 241, no. 4867, doi:doi:10.1126/science.3136547, pages 832 - 5, XP000572329 DOI: http://dx.doi.org/10.1126/science.3136547
	- CONKLIN, B. R. ET AL., "Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha", NATURE, (1993), vol. 363, no. 6426, doi:doi:10.1038/363274a0, pages 274 - 276, XP002199064 DOI: http://dx.doi.org/10.1038/363274a0
	- CONKLIN, B. R. ET AL., "Carboxyl-terminal mutations of Gq alpha and Gs alpha that alter the fidelity of receptor activation", MOL PHARMACOL, (1996), vol. 50, no. 4, pages 885 - 890, XP002090508
	- RASMUSSEN, S. G. ET AL., "Crystal structure of the ?2 adrenergic receptor-Gs protein complex", NATURE, (2011), vol. 477, no. 7366, pages 549 - 55
	- CHUNG, K. Y. ET AL., "Conformational changes in the G protein Gs induced by the beta2 adrenergic receptor", NATURE, (2011), vol. 477, no. 7366, pages 611 - 615
	- CHABRE, M. ET AL., "Molecular mechanism of visual transduction", EUR J BIOCHEM, (1989), vol. 179, no. 2, pages 255 - 266
	- DELEAN, A. ET AL., "A Ternary Complex Model Explains the Agonist-Specific Binding-Properties of the Adenylate Cyclase-Coupled Beta-Adrenergic-Receptor.", J BIOL CHEM, (1980), vol. 255, no. 15, pages 7108 - 17
	- BORNANCIN, F. ET AL., "The transitory complex between photoexcited rhodopsin and transducin. Reciprocal interaction between the retinal site in rhodopsin and the nucleotide site in transducin", EUR J BIOCHEM, (1989), vol. 184, no. 3, pages 687 - 98
	- SPRANG, S. R., "G protein mechanisms: insights from structural analysis", ANNU REV BIOCHEM, (1997), vol. 66, pages 639 - 78
	- FUNG, B. K., "Characterization of transducin from bovine retinal rod outer segments. I. Separation and reconstitution of the subunits", J BIOL CHEM, (1983), vol. 258, no. 17, pages 10495 - 10502
	- FUNG, B. K. ET AL., "Characterization of transducin from bovine retinal rod outer segments. II. Evidence for distinct binding sites and conformational changes revealed by limited proteolysis with trypsin", J BIOL CHEM, (1983), vol. 258, no. 17, pages 10503 - 10510
	- WITTINGHOFER, A. ET AL., "Structure-function relationships of the G domain, a canonical switch motif.", ANNU REV BIOCHEM, (2011), vol. 80, pages 943 - 971
	- HOLM L. ET AL., "Dali server: conservation mapping in 3D", NUCLEIC ACIDS RES, (2010), vol. 38, pages W545 - 9
	- HALL, A. ET AL., "The effect of Mg2+ on the guanine nucleotide exchange rate of p21N-ras", J BIOL CHEM, (1986), vol. 261, no. 24, pages 10963 - 10965
	- HIGASHIJIMA, T. ET AL., "Effects of Mg2+ and the beta gamma-subunit complex on the interactions of guanine nucleotides with G proteins", J BIOL CHEM, (1987), vol. 262, no. 2, pages 762 - 6
	- JONES, J. C. ET AL., "The crystal structure of a self-activating G protein alpha subunit reveals its distinct mechanism of Signal; initiation.", SCI SIGNAL, (2011), vol. 4, no. 159, doi:doi:10.1126/scisignal.2001446, page RA8, XP008184038 DOI: http://dx.doi.org/10.1126/scisignal.2001446
	- MAJUMDAR, S. ET AL., "Perturbing the linker regions of the alpha-subunit of transducin: a new class of constitutively active GTP-binding proteins", J BIOL CHEM, (2004), vol. 279, no. 38, pages 40137 - 40145
	- FERGUSON, K. M. ET AL., "The influence of bound GDP on the kinetics of guanine nucleotide binding to G proteins", J BIOL CHEM, (1986), vol. 261, no. 16, pages 7393 - 7399
	- POSNER, B. A. ET AL., "The A326S mutant of Gialpha1 as an approximation of the receptor-bound state", J BIOL CHEM, (1998), vol. 273, no. 34, doi:doi:10.1074/jbc.273.34.21752, pages 21752 - 21758, XP002553317 DOI: http://dx.doi.org/10.1074/jbc.273.34.21752
	- VETTER, I. R. ET AL., "The guanine nucleotide-binding switch in three dimensions", SCIENCE, (2001), vol. 294, no. 5545, pages 1299 - 1304, XP055168433
	- KAPOOR, N. ET AL., "Structural evidence for a sequential release mechanism for activation of heterotrimeric G proteins", J MOL BIOL, (2009), vol. 393, no. 4, doi:doi:10.1016/j.jmb.2009.08.043, pages 882 - 897, XP026692299 DOI: http://dx.doi.org/10.1016/j.jmb.2009.08.043
	- NATOCHIN, M. ET AL., "Probing the mechanism of rhodopsin-catalyzed transducin activation", J NEUROCHEM;, (2001), vol. 77, no. 1, pages 202 - 210
	- OLDHAM, W. M. ET AL., "Mechanism of the receptor-catalyzed activation of heterotrimeric G proteins", NAT STRUCT MOL BIOL, (2006), vol. 13, no. 9, pages 772 - 7
	- PREININGER, A. M. ET AL., "Helix dipole movement and conformational variability contribute to allosteric GDP release in Galphai subunits", BIOCHEMISTRY, (2009), vol. 48, no. 12, pages 2630 - 2642
	- ABDULAEV, N. G. ET AL., "Heterotrimeric G-protein alpha-subunit adopts a ''preactivated'' conformation when associated with betagamma-subunits", J BIOL CHEM, (2005), vol. 280, no. 45, pages 38071 - 38080
	- WEISS, E. R. ET AL., "Receptor activation of G proteins.", FASEB J, (1988), vol. 2, no. 13, pages 2841 - 2848
	- HOU, Y. ET AL., "Selective role of G protein gamma subunits in receptor interaction", J BIOL CHEM, (2000), vol. 275, no. 50, pages 38961 - 38964
	- MCLNTIRE, W. E. ET AL., "The G protein beta subunit is a determinant in the coupling of Gs to the beta 1-adrenergic and A2a adenosine receptors", J BIOL CHEM, (2001), vol. 276, no. 19, pages 15801 - 15809
	- RICHARDSON, M. ET AL., "The alpha2A-adrenergic receptor discriminates between Gi heterotrimers of different betagamma subunit composition in Sf9 insect cell membranes", J BIOL CHEM, (1999), vol. 274, no. 19, pages 13525 - 13533
	- SCHEERER, P.; HILDEBRAND ET AL., "Crystal structure of opsin in its G-protein-interacting conformation", NATURE, (2008), vol. 455, no. 7212, pages 497 - 502
	- CHOE, H. W. ET AL., "Crystal structure of metarhodopsin II", NATURE, (2011), vol. 471, no. 7340, pages 651 - 5
	- RASMUSSEN S. G. ET AL., "Structure of a nanobody-stabilized active state of the ?(2) adrenoceptor", NATURE, (2011), vol. 469, no. 7329, doi:doi:10.1038/NATURE09648, pages 175 - 80, XP002677648 DOI: http://dx.doi.org/10.1038/NATURE09648
	- ABDULAEV, N. G. ET AL., "The receptor-bound ''empty pocket'' state of the heterotrimeric G-protein alpha-subunit is conformationally dynamic", BIOCHEMISTRY, (2006), vol. 45, no. 43, pages 12986 - 12997
	- WESTFIELD, G. H. ET AL., "Structural flexibility of the G alpha s alpha-helical domain in the beta2-adrenoceptor Gs complex", PROC NATL ACAD SCI USA, (2011), vol. 108, no. 38, pages 16086 - 91
	- MARKBY D. W. ET AL., "Separate GTP binding and GTPase activating domains of a G alpha subunit", SCIENCE, (1993), vol. 262, no. 5141, doi:doi:10.1126/science.8266082, pages 1895 - 901, XP055360885 DOI: http://dx.doi.org/10.1126/science.8266082
	- DOHLMAN, H. G. ET AL., "Signal; activation and inactivation by the Galpha helical domain: a long-neglected partner in G protein signaling", SCI SIGNAL, (2012), vol. 5, no. 226, page RE2
	- PHILLIPS, W. J. ET AL., "Rhodopsin/transducin interactions. II. Influence of the transducin-beta gamma subunit complex on the coupling of the transducin-alpha subunit to rhodopsin", J BIOL CHEM, (1992), vol. 267, no. 24, pages 17040 - 6
	- SKIBA, N. ET AL., "Mapping of effector binding sites of transducin alpha-subunit using G alpha t/G alpha i1 chimeras", J BIOL CHEM, (1996), vol. 271, no. 1, pages 413 - 424
	- SINGH, G. ET AL., "A constitutively active Galpha subunit provides insights into the mechanism of G protein activation", BIOCHEMISTRY, (2012), vol. 51, no. 15, pages 3232 - 3240
	- HERRMANN, R ET AL., "Signal transfer from GPCRs to G proteins: role of the G alpha N-terminal region in rhodopsin-transducin coupling", J BIOL CHEM, (2006), vol. 281, no. 40, pages 30234 - 30241
	- BUBIS, J. ET AL., "Chemical modification of transducin with iodoacetic acid: transducin-alpha carboxymethylated at Cys(347) allows transducin binding to Light-activated rhodopsin but prevents its release in the presence of GTP", ARCH BIOCHEM; BIOPHYS, (2001), vol. 395, no. 2, pages 146 - 157
	- GRISHINA, G. ET AL., "A surface-exposed region of G(salpha) in which substitutions decrease receptor-mediated activation and increase receptor affinity", MOL PHARMACOL, (2000), vol. 57, no. 6, pages 1081 - 1092
	- BARREN, B. ET AL., "Mechanisms of dominant negative G-protein alpha subunits", J NEUROSCI RES, (2007), vol. 85, no. 16, pages 3505 - 3514
	- FEIG, L. A. ET AL., "Tools of the trade: use of dominant-inhibitory mutants of Ras-family GTPases", NAT CELL BIOL, (1999), vol. 1, no. 2, pages E25 - 27
	- FEIG, L. A. ET AL., "Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP.", MOL CELL BIOL, (1988), vol. 8, no. 8, pages 3235 - 3243
	- CLEATOR, J. H. ET AL., "The N54 mutant of Galphas has a conditional dominant negative phenotype which suppresses hormone-stimulated but not basal cAMP levels", FEBS LETT, (1999), vol. 443, no. 2, doi:doi:10.1016/S0014-5793(98)01704-9, pages 205 - 208, XP004259120 DOI: http://dx.doi.org/10.1016/S0014-5793(98)01704-9
	- CLEATOR, J. H. ET AL., "A dominant negative Galphas mutant that prevents thyroid-stimulating hormone receptor activation of cAMP production and inositol 1,4,5-trisphosphate turnover: competition by different G proteins for activation by a common receptor", J BIOL CHEM, (2004), vol. 279, no. 35, pages 36601 - 36607
	- HILDEBRANDT, J. D. ET AL., "A mutation in the putative Mg(2+)-binding site of Gs alpha prevents its activation by receptors", MOL CELL BIOL, (1991), vol. 11, no. 10, pages 4830 - 4838
	- NATOCHIN, M. ET AL., "Dominant negative mutants of transducin-alpha that block activated receptor", BIOCHEMISTRY, (2006), vol. 45, no. 20, pages 6488 - 6494
	- RAMACHANDRAN, S. ET AL., "A dominant-negative Galpha mutant that traps a stable rhodopsin-Galpha-GTP-betagamma complex", J BIOL CHEM, (2011), vol. 286, no. 14, pages 12702 - 12711
	- SLEPAK, V. Z. ET AL., "Functional analysis of a dominant negative mutant of G alpha i2", J BIOL CHEM, (1995), vol. 270, no. 8, pages 4037 - 4041
	- WU, Y. L. ET AL., "Dominant-negative inhibition of pheromone receptor signaling by a single point mutation in the G protein alpha subunit.", J BIOL CHEM, (2004), vol. 279, no. 34, pages 35287 - 35297
	- PEREIRA, R. ET AL., "A switch 3 point mutation in the alpha subunit of transducin yields a unique dominant-negative inhibitor", J BIOL CHEM, (2005), vol. 280, no. 42, pages 35696 - 35703
	- BARREN, B. ET AL., "Mutation R238E in transducin-alpha yields a GTPase and effector-deficient, but not dominant-negative, G-protein alpha-subunit.", MOL VIS, (2006), vol. 12, pages 492 - 498
	- ZURITA, A. R. ET AL., "The same mutation in Gsalpha and transducin alpha reveals behavioral differences between these highly homologous G protein alpha-subunits", PROC NATL ACAD SCI U S A, (2008), vol. 105, no. 7, pages 2363 - 2368
	- YU, B. ET AL., "Inhibition of subsets of G protein-coupled receptors by empty mutants of G protein alpha subunits in g(o): G(11): and G(16", J BIOL CHEM, (2000), vol. 275, no. 1, pages 71 - 76
	- YU, B. ET AL., "Interaction of the xanthine nucleotide binding Goalpha mutant with G protein-coupled receptors", J BIOL CHEM, (1998), vol. 273, no. 46, pages 30183 - 30188
	- YU, B. ET AL., "Characterization of a Goalpha mutant that binds xanthine nucleotides.", J BIOL CHEM, (1997), vol. 272, no. 29, pages 18015 - 18019
	- LIRI, T. ET AL., "Gsalpha mutant designed to inhibit receptor signaling through Gs", PROC NATL ACAD SCI USA, (1999), vol. 96, no. 2, pages 499 - 504
	- LIRI, T. ET AL., "Rapid GDP release from Gs alpha in patients with gain and loss of endocrine function", NATURE, (1994), vol. 371, no. 6493, pages 164 - 168
	- WARNER, D. R. ET AL., "A novel mutation in the switch 3 region of Gsalpha in a patient with Albright hereditary osteodystrophy impairs GDP binding and receptor activation", J BIOL CHEM, (1998), vol. 273, no. 37, doi:doi:10.1074/jbc.273.37.23976, pages 23976 - 23983, XP001094001 DOI: http://dx.doi.org/10.1074/jbc.273.37.23976
	- BERLOT, C. H. ET AL., "A highly effective dominant negative alpha s construct containing mutations that affect distinct functions inhibits multiple Gs-coupled receptor signaling pathways", J BIOL CHEM, (2002), vol. 277, no. 23, pages 21080 - 21085
	- SERRANO-VEGA, M. J. ET AL., "Conformational thermostabilization of the beta1-adrenergic receptor in a detergent-resistant form", PROC NATL ACAD SCI U S A, (2008), vol. 105, no. 3, doi:doi:10.1073/pnas.0711253105, pages 877 - 882, XP002487473 DOI: http://dx.doi.org/10.1073/pnas.0711253105
	- JOHNSTON, C. A. ET AL., "Structure of Ga!pha(i1) bound to a GDP-selective peptide provides insight into guanine nucleotide exchange.", STRUCTURE, (2005), vol. 13, no. 7, pages 1069 - 1080
	- KIMPLE, R. J. ET AL., "Structural determinants for GoLoco-induced inhibition of nucleotide release by Galpha subunits", NATURE, (2002), vol. 416, no. 6883, pages 878 - 881
	- NISHIMURA, A. ET AL., "Structural basis for the specific inhibition of heterotrimeric Gq protein by a small molecule", PROC NATL ACAD SCI U S A, (2010), vol. 107, no. 31, pages 13666 - 13671
	- UMEZAWA, Y. ET AL., "CH/pi interactions as demonstrated in the crystal structure of guanine-nucleotide binding proteins, Src homology-2 domains and human growth hormone in complex with their specific ligands.", BIOORG MED CHEM, (1998), vol. 6, no. 4, pages 493 - 504
	- LI, Q. ET AL., "Communication between switch II and switch III of the transducin alpha subunit is essential for target activation", J BIOL CHEM, (1997), vol. 272, no. 35, pages 21673 - 21676
	- FRISHMAN, D. ET AL., "Knowledge-based protein secondary structure assignment", PROTEINS, vol. 23, no. 4, pages 566 - 579
	- HEINIG, M. ET AL., "STRIDE: a web server for secondary structure assignment from known atomic coordinates of proteins", NUCLEIC ACIDS RES, (2004), vol. 32, pages W500 - 502
	- MURADOV, K. G. ET AL., "Coupling between the N- and C-terminal domains influences transducin-alpha intrinsic GDP/GTP exchange", BIOCHEMISTRY, (2000), vol. 39, no. 14, pages 3937 - 3942
	- LAMBRIGHT, D. G. ET AL., "Structural determinants for activation of the alpha-subunit of a heterotrimeric G protein", NATURE, (1994), vol. 369, no. 6482, pages 621 - 628
	- COLEMAN, D. E ET AL., "Crystal structures; of the G protein Gi alpha 1 complexed with GDP and Mg2+: a crystallographic titration experiment", BIOCHEMISTRY, (1998), vol. 37, no. 41, pages 14376 - 14385
	- NOEL, J. P. ET AL., "The 2.2 A crystal structure of transducin-alpha complexed with GTP gamma S.", NATURE, (1993), vol. 366, no. 6456, doi:doi:10.1038/366654a0, pages 654 - 663, XP000919145 DOI: http://dx.doi.org/10.1038/366654a0
	- SUNAHARA, R. K. ET AL., "Crystal structure of the adenylyl cyclase activator Gsalpha", SCIENCE, (1997), vol. 278, no. 5345, pages 1943 - 7
	- TESMER, J. J. ET AL., "Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS", SCIENCE, (1997), vol. 278, no. 5345, pages 1907 - 1916
	- KLEUSS, C. ET AL., "Galpha(s) is palmitoylated at the N-terminal glycine.", EMBO J, (2003), vol. 22, no. 4, pages 826 - 832
	- SIMONDS, W. F. ET AL., "G-protein beta gamma dimers. Membrane targeting requiRes; subunit coexpression and intact gamma C-A-A-X domain", J BIOL CHEM, (1991), vol. 266, no. 9, pages 5363 - 5366
	- SPIEGEL, A. M. ET AL., "The G protein connection: molecular basis of membrane association", TRENDS BIOCHEM SCI, (1991), vol. 16, no. 9, doi:doi:10.1016/0968-0004(91)90139-M, pages 338 - 41, XP025864794 DOI: http://dx.doi.org/10.1016/0968-0004(91)90139-M
	- HERRMANN, R. ET AL., "Signal; transfer from GPCRs to G proteins: role of the G alpha N-terminal region in rhodopsin-transducin coupling", J BIOL CHEM, (2006), vol. 281, no. 40, pages 30234 - 41
	- ALEXANDER, N. S. ET AL., "Energetic analysis of the rhodopsin-G-protein complex links the a5 helix to GDP release", NAT STRUCT MOL BIOL, (2014), vol. 21, no. 1, pages 56 - 63
	- DROR, R. O. ET AL., "SIGNAL; TRANSDUCTION. Structural basis for nucleotide exchange in heterotrimeric G proteins", SCIENCE, (2015), vol. 348, no. 6241, pages 1361 - 5
	- FLOCK, T. ET AL., "Universal allosteric mechanism for Ga activation by GPCRs", NATURE, (2015), vol. 524, no. 7564, doi:doi:10.1038/nature14663, pages 173 - 9, XP055371482 DOI: http://dx.doi.org/10.1038/nature14663
	- KAYA, A. I. ET AL., "A conserved phenylalanine as a relay between the a5 helix and the GDP binding region of heterotrimeric Gi protein ? subunit", J BIOL CHEM, (2014), vol. 289, no. 35, pages 24475 - 87
	- VAN EPS, N. ET AL., "Interaction of a G protein with an activated receptor opens the interdomain interface in the alpha subunit", PROC NATL ACAD SCI USA, (2011), vol. 108, no. 23, pages 9420 - 4
	- SUN, D. ET AL., "Probing Gai1 protein activation at single-amino acid resolution", NAT STRUCT MOL BIOL, (2015), vol. 22, no. 9, doi:doi:10.1038/nsmb.3070, pages 686 - 94, XP055231369 DOI: http://dx.doi.org/10.1038/nsmb.3070
	- VUONG T. M. ET AL., "Millisecond activation of transducin in the cyclic nucleotide cascade of vision", NATURE, (1984), vol. 311, no. 5987, pages 659 - 61
	- KUHN, H., "Interactions of rod cell proteins with the disc membrane: influence of light, ionic strength, and nucleotides", CURRTOP MEMBRTRANSP, (1981), vol. 15, pages 171 - 201
	- FUNG, B. K. ET AL., "Flow of information in the light-triggered cyclic nucleotide cascade of vision.", PROC NATL ACAD SCI; U S A, (1981), vol. 78, no. 1, pages 152 - 6
	- MILLER-GALLACHER, R. ET AL., "The 2.1 A Resolution Structure of Cyanopindolol-Bound ?I-Adrenoceptor Identifies an Intramembrane Na+ Ion that Stabilises the Ligand-Free Receptor.", PLOS ONE, (2014), vol. 9, no. 3, page E92727
	- WARNE, T. ET AL., "Expression and purification of truncated, non-glycosylated turkey beta-adrenergic receptors for crystallization", BIOCHIM BIOPHYS ACTA, (2003), vol. 1610, no. 1, doi:doi:10.1016/S0005-2736(02)00716-2, pages 133 - 40, XP004409764 DOI: http://dx.doi.org/10.1016/S0005-2736(02)00716-2
	- HANZAL-BAYER, M. ET AL., "The complex of Arl2-GTP and PDE delta: from structure to function", EMBO J, (2002), vol. 21, no. 9, pages 2095 - 106
	- TRAUT, T. W., "Physiological concentrations of purines and pyrimidines", MOL CELL BIOCHEM, (1994), vol. 140, no. 1, pages 1 - 22
	- RING A. M. ET AL., "Adrenaline-activated structure of p2-adrenoceptor stabilized by an engineered nanobody.", NATURE, (2013), vol. 502, no. 7472, doi:doi:10.1038/nature12572, pages 575 - 9, XP055162506 DOI: http://dx.doi.org/10.1038/nature12572
	- WEICHERT D. ET AL., "Covalent agonists for studying G protein-coupled receptor activation", PROC NATL ACAD SCI U S A, (2014), vol. 111, no. 29, pages 10744 - 8
	- HANSSON K, M. D. ET AL., "PCR-mediated deletion of plasmid DNA", ANAL BIOCHEM, (2008), vol. 375, no. 2, doi:doi:10.1016/j.ab.2007.12.005, pages 373 - 5, XP029159990 DOI: http://dx.doi.org/10.1016/j.ab.2007.12.005
	- FLOCK, T. ET AL., "Universal allosteric mechanism for Go activation by GPCRs", NATURE, (2015), vol. 524, no. 7564, doi:doi:10.1038/nature14663, pages 173 - 9, XP055371482 DOI: http://dx.doi.org/10.1038/nature14663
	- FREDHOLM, B.B. ET AL., "International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.", PHARMACOL REV, (2001), vol. 53, no. 4, pages 527 - 552
	- FREDHOLM, B.B. ET AL., "International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.", PHARMACOL REV, (2011), vol. 63, no. 1, doi:doi:10.1124/pr.110.003285, pages 1 - 34, XP055162854 DOI: http://dx.doi.org/10.1124/pr.110.003285
	- CHEN, J.F ET AL., "Adenosine receptors as drug targets-what are the challenges?", NAT REV DRUG DISCOV, (2013), vol. 12, no. 4, pages 265 - 286
	- MULLER, C.E. ET AL., "Recent developments in adenosine receptor ligands and their potential as novel drugs", BIOCHIM BIOPHYS ACTA, (2011), vol. 1808, no. 5, doi:doi:10.1016/j.bbamem.2010.12.017, pages 1290 - 1308, XP028157805 DOI: http://dx.doi.org/10.1016/j.bbamem.2010.12.017
	- CONGREVE, M. ET AL., "Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design.", JOURNAL OF MEDICINAL CHEMISTRY, (2012), vol. 55, no. 5, pages 1898 - 1903
	- FISHMAN, P. ET AL., "Pharmacological and therapeutic effects of A3 adenosine receptor agonists.", DRUG DISCOV TODAY, (2012), vol. 17, no. 7-8, doi:doi:10.1016/j.drudis.2011.10.007, pages 359 - 366, XP055056218 DOI: http://dx.doi.org/10.1016/j.drudis.2011.10.007
	- DORE, A.S. ET AL., "Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine", STRUCTURE, (2011), vol. 19, no. 9, doi:doi:10.1016/j.str.2011.06.014, pages 1283 - 1293, XP055023683 DOI: http://dx.doi.org/10.1016/j.str.2011.06.014
	- HINO, T. ET AL., "G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody.", NATURE, (2012), vol. 482, no. 7384, pages 237 - 240
	- JAAKOLA, V.P. ET AL., "The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist", SCIENCE, (2008), vol. 322, no. 5905, doi:doi:10.1126/science.1164772, pages 1211 - 1217, XP055004447 DOI: http://dx.doi.org/10.1126/science.1164772
	- LEBON, G. ET AL., "Molecular Determinants of CGS21680 Binding to the Human Adenosine A2A Receptor", MOL PHARMACOL, (2015), vol. 87, no. 6, pages 907 - 915
	- LEBON, G. ET AL., "Agonist-bound structures of G protein-coupled receptors", CURRENT OPINION IN STRUCTURAL BIOLOGY, (2012), vol. 22, no. 4, pages 482 - 90
	- LIU, W. ET AL., "Structural basis for allosteric regulation of GPCRs by sodium ions.", SCIENCE, (2012), vol. 337, no. 6091, doi:doi:10.1126/science.1219218, pages 232 - 236, XP055200845 DOI: http://dx.doi.org/10.1126/science.1219218
	- FENALTI, G. ET AL., "Molecular control of delta-opioid receptor signalling", NATURE, (2014), vol. 506, no. 7487, doi:doi:10.1038/nature12944, pages 191 - 196, XP055254889 DOI: http://dx.doi.org/10.1038/nature12944
	- ZHANG, C. ET AL., "High-resolution crystal structure of human protease-activated receptor 1", NATURE, (2012), vol. 492, no. 7429, pages 387 - 392
	- MURPHREE, L.J. ET AL., "Human A(2A) adenosine receptors: high-affinity agonist binding to receptor-G protein complexes containing Gbeta(4", MOL PHARMACOL, (2002), vol. 61, no. 2, pages 455 - 462
	- MANGLIK, A. ET AL., "Structural Insights into the Dynamic Process of beta2-Adrenergic Receptor Signaling.", CELL, (2015), vol. 161, no. 5, doi:doi:10.1016/j.cell.2015.04.043, pages 1101 - 1111, XP029129137 DOI: http://dx.doi.org/10.1016/j.cell.2015.04.043
	- BALLESTEROS, J.A. ET AL., "Integrated methods for the construction of three dimensional models and computational probing of structure function relations in G protein-coupled receptors.", METHODS IN NEUROSCIENCES, (1995), vol. 25, doi:doi:10.1016/S1043-9471(05)80049-7, pages 366 - 428, XP009139377 DOI: http://dx.doi.org/10.1016/S1043-9471(05)80049-7
	- PARK, J.H. ET AL., "Crystal structure of the ligand-free G-protein-coupled receptor opsin", NATURE, (2008), vol. 454, no. 7201, pages 183 - 187
	- KRUMM, B.E. ET AL., "Structural prerequisites for G-protein activation by the neurotensin receptor", NAT COMMUN, (2015), vol. 6, page 7895
	- WHITE, J.F. ET AL., "Structure of the agonist-bound neurotensin receptor", NATURE, (2012), vol. 490, no. 7421, pages 508 - 513
	- LESLIE, A. G., "The integration of macromolecular diffraction data.", ACTA CRYSTALLOGR D BIOL CRYSTALLOGR, (2006), vol. 62, pages 48 - 57
	- EVANS, P. R. ET AL., "How good are my data and what is the resolution?", ACTA CRYST. D BIOL CRYSTALLOGR, (2013), vol. 69, pages 1204 - 1214
	- MCCOY, A. J. ET AL., "Phaser crystallographic software.", J APPL CRYSTALLOGR, (2007), vol. 40, pages 658 - 674
	- MURSHUDOV, G. N ET AL., "REFMAC5 for the refinement of macromolecular crystal structures", ACTA CRYSTALLOGR D BIOL CRYSTALLOGR, (2011), vol. 67, pages 355 - 367
	- EMSLEY, P. ET AL., "Features and development of Coot.", ACTA CRYSTALLOGR D BIOL CRYSTALLOGR, (2010), vol. 66, pages 486 - 501
	- ROSENBAUM DM; RASMUSSEN SG; KOBILKA BK., "The structure and function of G-protein-coupled receptors", NATURE, (2009), vol. 459, no. 7245, doi:doi:10.1038/nature08144, pages 356 - 63, XP002717089 DOI: http://dx.doi.org/10.1038/nature08144
	- RASMUSSEN SG; DEVREE BT; ZOU Y; KRUSE AC; CHUNG KY; KOBILKA TS ET AL., "Crystal structure of the beta2 adrenergic receptor-Gs protein complex", NATURE, (20110721), vol. 477, no. 7366, pages 549 - 55
	- TATE CG; SCHERTLER GF., "Engineering G protein-coupled receptors to facilitate their structure determination.", CURR OPIN STRUCT BIOL., (20090818), vol. 19, no. 4, doi:doi:10.1016/j.sbi.2009.07.004, pages 386 - 95, XP026541926 DOI: http://dx.doi.org/10.1016/j.sbi.2009.07.004
	- VENKATAKRISHNAN AJ; DEUPI X; LEBON G; TATE CG; SCHERTLER GF; BABU MM., "Molecular signatures of G-protein-coupled receptors.", NATURE, (20130215), vol. 494, no. 7436, pages 185 - 94
	- VENKATAKRISHNAN AJ; DEUPI X; LEBON G; HEYDENREICH FM; FLOCK T; MILJUS T ET AL., "Diverse activation pathways in class A GPCRs converge near the G-protein-coupling region", NATURE, (2016), vol. 536, no. 7617, pages 484 - 7
	- FLOCK T; RAVARANI CN; SUN D; VENKATAKRISHNAN AJ; KAYIKCI M; TATE CG ET AL., "Universal allosteric mechanism for Galpha activation by GPCRs.", NATURE, (20150707), vol. 524, no. 7564, doi:doi:10.1038/nature14663, pages 173 - 9, XP055371482 DOI: http://dx.doi.org/10.1038/nature14663
	- WARNE T; MOUKHAMETZIANOV R; BAKER JG; NEHME R; EDWARDS PC; LESLIE AG ET AL., "The structural basis for agonist and partial agonist action on a beta(1)-adrenergic receptor", NATURE, (20110114), vol. 469, no. 7329, pages 241 - 4
	- ROSENBAUM DM; ZHANG C; LYONS JA; HOLL R; ARAGAO D; ARLOW DH ET AL., "Structure and function of an irreversible agonist-beta(2) adrenoceptor complex", NATURE, (20110114), vol. 469, no. 7329, pages 236 - 40
	- ZHANG J; ZHANG K; GAO ZG; PAOLETTA S; ZHANG D; HAN GW ET AL., "Agonist-bound structure of the human P2Y12 receptor", NATURE, vol. 509, no. 7498, doi:doi:10.1038/nature13288, pages 119 - 22, XP055200854 DOI: http://dx.doi.org/10.1038/nature13288
	- WANG C; JIANG Y; MA J; WU H; WACKER D; KATRITCH V ET AL., "Structural basis for molecular recognition at serotonin receptors", SCIENCE, (2013), vol. 340, no. 6132, pages 610 - 4
	- LEBON G; WARNE T; EDWARDS PC; BENNETT K; LANGMEAD CJ; LESLIE AG ET AL., "Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation", NATURE, (20110520), vol. 474, no. 7352, pages 521 - 5
	- XU F; WU H; KATRITCH V; HAN GW; JACOBSON KA; GAO ZG ET AL., "Structure of an agonist-bound human A2A adenosine receptor", SCIENCE, (20110312), vol. 332, no. 6027, doi:doi:10.1126/science.1202793, pages 322 - 7, XP002680157 DOI: http://dx.doi.org/10.1126/science.1202793
	- WHITE JF; NOINAJ N; SHIBATA Y; LOVE J; KLOSS B; XU F ET AL., "Structure of the agonist-bound neurotensin receptor", NATURE, (20121012), vol. 490, no. 7421, pages 508 - 13
	- RASMUSSEN SG; CHOI HJ; FUNG JJ; PARDON E; CASAROSA P; CHAE PS ET AL., "Structure of a nanobody-stabilized active state of the beta(2) adrenoceptor", NATURE, (20110114), vol. 469, no. 7329, doi:doi:10.1038/NATURE09648, pages 175 - 80, XP002677648 DOI: http://dx.doi.org/10.1038/NATURE09648
	- CHOE HW; KIM YJ; PARK JH; MORIZUMI T; PAI EF; KRAUSS N ET AL., "Crystal structure of metarhodopsin II", NATURE, (2011), vol. 471, no. 7340, pages 651 - 5
	- STANDFUSS J; EDWARDS PC; D'ANTONA A; FRANSEN M; XIE G; OPRIAN DD ET AL., "The structural basis of agonist-induced activation in constitutively active rhodopsin.", NATURE, (2011), vol. 471, no. 7340, pages 656 - 60
	- KRUSE AC; RING AM; MANGLIK A; HU J; HU K; EITEL K ET AL., "Activation and allosteric modulation of a muscarinic acetylcholine receptor.", NATURE, (2013), vol. 504, no. 7478, doi:doi:10.1038/nature12735, pages 101 - 6, XP055108116 DOI: http://dx.doi.org/10.1038/nature12735
	- SOUNIER R; MAS C; STEYAERT J; LAEREMANS T; MANGLIK A; HUANG W ET AL., "Propagation of conformational changes during mu-opioid receptor activation", NATURE, (2015), vol. 524, no. 7565, pages 375 - 8
	- CARPENTER B; NEHME R; WARNE T; LESLIE AG; TATE CG., "Structure of the adenosine A(2A) receptor bound to an engineered G protein", NATURE, (20160728), vol. 536, no. 7614, pages 104 - 7
	- PARK JH; SCHEERER P; HOFMANN KP; CHOE HW; ERNST OP., "Crystal structure of the ligand-free G-protein-coupled receptor opsin.", NATURE, (20080620), vol. 454, no. 7201, pages 183 - 7
	- SCHEERER P; PARK JH; HILDEBRAND PW; KIM YJ; KRAUSS N; CHOE HW ET AL., "Crystal structure of opsin in its G-protein-interacting conformation.", NATURE, (20080927), vol. 455, no. 7212, pages 497 - 502
	- PARDON E; LAEREMANS T; TRIEST S; RASMUSSEN SG; WOHLKONIG A; RUF A ET AL., "A general protocol for the generation of Nanobodies for structural biology", NAT PROTOC, (2014), vol. 9, no. 3, doi:doi:10.1038/nprot.2014.039, pages 674 - 93, XP055161463 DOI: http://dx.doi.org/10.1038/nprot.2014.039
	- CARPENTER B; TATE CG., "Engineering a minimal G protein to facilitate crystallisation of G protein-coupled receptors in their active conformation", PROTEIN ENGINEERING, DESIGN & SELECTION : PEDS, (20160928), vol. 29, no. 12, pages 583 - 94, XP002770055 DOI: http://dx.doi.org/10.1093/protein/gzw049
	- SYROVATKINA V; ALEGRE KO; DEY R; UANG XY, "Regulation, Signaling, and Physiological Functions of G-Proteins", JOURNAL OF MOLECULAR BIOLOGY, (20160816), vol. 428, no. 19, doi:doi:10.1016/j.jmb.2016.08.002, pages 3850 - 68, XP029721377 DOI: http://dx.doi.org/10.1016/j.jmb.2016.08.002
	- WARNE T; CHIRNSIDE J; SCHERTLER GF., "Expression and purification of truncated, non-glycosylated turkey beta-adrenergic receptors for crystallization", BIOCHIM BIOPHYS ACTA, (2003), vol. 1610, no. 1, doi:doi:10.1016/S0005-2736(02)00716-2, pages 133 - 40, XP004409764 DOI: http://dx.doi.org/10.1016/S0005-2736(02)00716-2
	- WARNE T; SERRANO-VEGA MJ; BAKER JG; MOUKHAMETZIANOV R; EDWARDS PC; HENDERSON R ET AL., "Structure of a beta1-adrenergic G-protein-coupled receptor", NATURE, (20080703), vol. 454, no. 7203, doi:doi:10.1038/nature07101, pages 486 - 91, XP055049710 DOI: http://dx.doi.org/10.1038/nature07101
	- THOMAS J; TATE CG., "Quality control in eukaryotic membrane protein overproduction.", J MOL BIOL., (2014), vol. 426, no. 24, doi:doi:10.1016/j.jmb.2014.10.012, pages 4139 - 54, XP029108169 DOI: http://dx.doi.org/10.1016/j.jmb.2014.10.012
	- LEBON G; BENNETT K; JAZAYERI A; TATE CG., "Thermostabilisation of an agonist-bound conformation of the human adenosine A(2A) receptor", J MOL BIOL., (2011), vol. 409, no. 3, doi:doi:10.1016/j.jmb.2011.03.075, pages 298 - 310, XP055004363 DOI: http://dx.doi.org/10.1016/j.jmb.2011.03.075
	- SHIBATA Y; WHITE JF; SERRANO-VEGA MJ; MAGNANI F; ALOIA AL; GRISSHAMMER R ET AL., "Thermostabilization of the neurotensin receptor NTS1.", J MOL BIOL., (20090509), vol. 390, no. 2, doi:doi:10.1016/j.jmb.2009.04.068, pages 262 - 77, XP026174194 DOI: http://dx.doi.org/10.1016/j.jmb.2009.04.068
	- CHAN P; THOMAS CJ; SPRANG SR; TALL GG., "Molecular chaperoning function of Ric-8 is to fold nascent heterotrimeric G protein alpha subunits.", PROC NATL ACAD SCI USA., (2013), vol. 110, no. 10, pages 3794 - 9
	- GREEN SA; HOLT BD; LIGGETT SB., "Beta 1- and beta 2-adrenergic receptors display subtype-selective coupling to Gs", MOL PHARMACOL., (1992), vol. 41, no. 5, pages 889 - 93
	- TATE CG., "A crystal clear solution for determining G-protein-coupled receptor structures", TRENDS IN BIOCHEMICAL SCIENCES, (2012), vol. 37, no. 9, doi:doi:10.1016/j.tibs.2012.06.003, pages 343 - 52, XP055121930 DOI: http://dx.doi.org/10.1016/j.tibs.2012.06.003
	- MAGNANI F; SERRANO-VEGA MJ; SHIBATA Y; ABDUL-HUSSEIN S; LEBON G; MILLER-GALLACHER J ET AL., "A mutagenesis and screening strategy to generate optimally thermostabilized membrane proteins for structural studies", NAT PROTOC., (2016), vol. 11, no. 8, pages 1554 - 71
	- ZHANG X; STEVENS RC; XU F., "The importance of ligands for G protein-coupled receptor stability.", TRENDS IN BIOCHEMICAL SCIENCES, (2015), vol. 40, no. 2, pages 79 - 87
	- KAWATE T; GOUAUX E., "Fluorescence-detection size-exclusion chromatography for precrystallization screening of integral membrane proteins", STRUCTURE, (2006), vol. 14, no. 4, doi:doi:10.1016/j.str.2006.01.013, pages 673 - 81, XP025133935 DOI: http://dx.doi.org/10.1016/j.str.2006.01.013
	- KULL B; SVENNINGSSON P; FREDHOLM BB, "Adenosine A(2A) receptors are colocalized with and activate g(olf) in rat striatum.", MOLECULAR PHARMACOLOGY, (20000922), vol. 58, no. 4, pages 771 - 7
	- CHAN P; GABAY M; WRIGHT FA; KAN W; ONER SS; LANIER SM ET AL., "Purification of heterotrimeric G protein alpha subunits by GST-Ric-8 association: primary characterization of purified G alpha(olf", J BIOL CHEM., (2011), vol. 286, no. 4, pages 2625 - 35
	- SERRANO-VEGA MJ; TATE CG., "Transferability of thermostabilizing mutations between beta-adrenergic receptors", MOL MEMBR BIOL., (20091104), vol. 26, no. 8, pages 385 - 96, XP009141885
	- HAMM HE; DERETIC D; ARENDT A; HARGRAVE PA; KOENIG B; HOFMANN KP., "Site of G protein binding to rhodopsin mapped with synthetic peptides from the alpha subunit", SCIENCE, (19880812), vol. 241, no. 4867, doi:doi:10.1126/science.3136547, pages 832 - 5, XP000572329 DOI: http://dx.doi.org/10.1126/science.3136547
	- CONKLIN BR; FARFEL Z; LUSTIG KD; JULIUS D; BOURNE HR, "Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha", NATURE, (19930520), vol. 363, no. 6426, doi:doi:10.1038/363274a0, pages 274 - 6, XP002199064 DOI: http://dx.doi.org/10.1038/363274a0
	- CONKLIN BR; HERZMARK P; ISHIDA S; VOYNO-YASENETSKAYA TA; SUN Y; FARFEL Z ET AL., "Carboxyl-terminal mutations of Gq alpha and Gs alpha that alter the fidelity of receptor activation", MOL PHARMACOL., (19961001), vol. 50, no. 4, pages 885 - 90, XP002090508
	- SEMACK A; SANDHU M; MALIK RU; VAIDEHI N; SIVARAMAKRISHNAN S., "Structural Elements in the Galphas and Galphaq C Termini That Mediate Selective G Protein-coupled Receptor (GPCR) Signaling", J BIOL CHEM., (2016), vol. 291, no. 34, pages 17929 - 40
	- NISHIMURA A; KITANO K; TAKASAKI J; TANIGUCHI M; MIZUNO N; TAGO K ET AL., "Structural basis for the specific inhibition of heterotrimeric Gq protein by a small molecule", PROC NATL ACAD SCI USA., (2010), vol. 107, no. 31, pages 13666 - 71
	- TESMER VM; KAWANO T; SHANKARANARAYANAN A; KOZASA T; TESMER JJ., "Snapshot of activated G proteins at the membrane: the Galphaq-GRK2-Gbetagamma complex", SCIENCE, (2005), vol. 310, no. 5754, pages 1686 - 90
	- CLAWGES HM; DEPREE KM; PARKER EM; GRABER SG., "Human 5-HT1 receptor subtypes exhibit distinct G protein coupling behaviors in membranes from Sf9 cells", BIOCHEMISTRY, (19971023), vol. 36, no. 42, doi:doi:10.1021/bi970112b, pages 12930 - 8, XP055043177 DOI: http://dx.doi.org/10.1021/bi970112b
	- TATE CG., "Practical considerations of membrane protein instability during purification and crystallisation", METHODS MOL BIOL, (2010), vol. 601, pages 187 - 203

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p